- Home
- GROV vs ALGS Comparison
GROV vs ALGS Comparison
Compare GROV & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GROV | ALGS |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0M | 57.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GROV | ALGS |
|---|---|---|
| Price | $1.25 | $12.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.60 | ★ $60.00 |
| AVG Volume (30 Days) | 68.4K | ★ 81.5K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $180,808,000.00 | $2,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.02 | $3.76 |
| 52 Week High | $1.95 | $46.80 |
Technical Indicators
Market Signals| Indicator | GROV | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 40.43 | 67.32 |
| Support Level | $1.22 | $9.10 |
| Resistance Level | $1.35 | $10.45 |
| Average True Range (ATR) | 0.05 | 0.84 |
| MACD | -0.00 | 0.34 |
| Stochastic Oscillator | 24.32 | 66.24 |
Price Performance
Historical ComparisonAbout GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.